KNSA

KINIKSA PHARMACEUTICALS INTL

KNSA·G52694109·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-Activist

KNSA (KINIKSA PHARMACEUTICALS INTL) is held by 145 institutional investors as of Q2 2026. Largest holders: FMR LLC ($445.8M), BAKER BROS. ADVISORS LP ($181.3M), BlackRock, Inc. ($175.2M). Net institutional sentiment: Mixed.

145
Holders
(12 Elite)
$2.1B
Total Value
60% (146)
Consensus
87 buying - 59 selling
13F: Insider & Congress: Updated regularly
KNSA

Smart Money Verdict

View all
Loading verdict
Held by 145 funds
12 elite

Who's Trading

Source dates: Price Aug 21, 2026 · Insiders Aug 21, 2026 · Activists Jul 29, 2026 · Congress none

InsiderQDQuart Barry DGift 3K shAug 19, 2026
ActivistBlackRock, Inc.BlackRock, Inc.5.5%Jul 29, 2026
ActivistBaker Bros. Advisors LPBaker Bros. Advisors LP6.9%May 26, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
7M(+2.2%)$445.8M0.0%+86.70%
32
Increased
2.8M(+0.3%)$181.3M0.9%+319.54%
43
Increased
2.7M(+462.9%)$175.2M0.0%+40.00%
49
Increased
1.9M(+8.2%)$122.2M0.0%+68.94%
33
Increased
1.4M(+2.1%)$87M0.0%+72.75%
30
Increased
1M(+1.3%)$64.7M0.0%+231.94%
30
Increased
957,514(+7.3%)$61.2M0.0%+135.29%
32
Increased
874,786(+7.7%)$55.9M0.0%+185.86%
32
Increased
772,806(+2694.3%)$49.4M0.0%+25.98%
47
Increased
718,199(+17.5%)$45.9M0.3%+194.71%
41
Increased
704,194(+818.9%)$45M0.0%+33.44%
47
Increased
659,493(+2.9%)$42.2M0.0%+170.07%
30
Decreased
608,650(-2.4%)$38.9M0.0%+323.30%
0
Increased
604,180(+1263.2%)$38.6M0.0%+30.31%
47
Decreased
572,598(-11.9%)$36.6M0.1%+203.93%
0
Decreased
569,756(-40.6%)$36.4M0.0%+161.97%
0
Increased
561,480(+33.4%)$35.9M0.0%+84.62%
37
Decreased
504,853(-0.3%)$32.3M0.0%+92.80%
0
Decreased
437,192(-32.5%)$28M0.0%+145.34%
0
Decreased
431,324(-1.5%)$27.6M0.0%+118.05%
0

Showing 1-20 of 153

1 / 8
KNSAKNSAKINIKSA PHARMACEUTICALS INTL

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used